1987
DOI: 10.1254/jjp.44.393
|View full text |Cite
|
Sign up to set email alerts
|

Effect of long-term dosing with tiapride on brain dopamine receptors and metabolism in rats. Comparative study with sulpiride and haloperidol.

Abstract: Abstract-The effects of long-term dosing with tiapride for 21 days on barin dopa mine receptors and dopamine turnover were compared with those of sulpiride and haloperidol. Haloperidol caused an increase in both antagonist (3H-spiperone) labeled receptors and agonist (3H-N,n-propylnorapomorphine) labeled ones, whereas tiapride acted on the agonist binding sites and sulpiride acted on the antagonist binding sites. The increases induced by sulpiride were only observed

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

1988
1988
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 24 publications
0
4
0
Order By: Relevance
“…Other evidence suggests that radiolabeled benzamides, such as raclopride and sulpiride, may differ from spiperone in the sites that are labeled (Theodorou et al, 1980;Zahniser et al, 1983) and may preferentially bind to a subclass of D2 receptors (Kohler et al, 1979;Memo et al, 1980;Ogren et al, 1986). Rats treated with sulpiride for 4 weeks (Rupniak et al, 1984a) or 12 months (Rupniak et al, 1984b) showed no increase in [3H]spiperone binding, although they did show an increase in [3H-lN-,n-propylnorapomorphine (NPA), a D2 receptor ligand which differs from [3H]spiperone (Battaglia and Titeler, 1982); similar results were found after chronic tiapride (Satoh et al, 1987). The results of the present study, in which raclopride-treated animals showed signs of increased D2 binding with [3H]raclopride, but not [3H]spiperone, suggests the possibility that raclopride is preferentially acting at a subpopulation of D2 receptors, resulting in a selective upregulation.…”
Section: Discussionmentioning
confidence: 69%
“…Other evidence suggests that radiolabeled benzamides, such as raclopride and sulpiride, may differ from spiperone in the sites that are labeled (Theodorou et al, 1980;Zahniser et al, 1983) and may preferentially bind to a subclass of D2 receptors (Kohler et al, 1979;Memo et al, 1980;Ogren et al, 1986). Rats treated with sulpiride for 4 weeks (Rupniak et al, 1984a) or 12 months (Rupniak et al, 1984b) showed no increase in [3H]spiperone binding, although they did show an increase in [3H-lN-,n-propylnorapomorphine (NPA), a D2 receptor ligand which differs from [3H]spiperone (Battaglia and Titeler, 1982); similar results were found after chronic tiapride (Satoh et al, 1987). The results of the present study, in which raclopride-treated animals showed signs of increased D2 binding with [3H]raclopride, but not [3H]spiperone, suggests the possibility that raclopride is preferentially acting at a subpopulation of D2 receptors, resulting in a selective upregulation.…”
Section: Discussionmentioning
confidence: 69%
“…Hence, it is likely that differences in results between different studies might be due to experimental conditions (e. g., dosing i. p. or oral application, time interval between drug application and measurement, chemicals, etc. ), as stated by Satoh et al [25] themselves. Nevertheless, a measurable acute effect of tiapride on the dopaminergic systems can be assumed when the drug is given in a medium or high dose.…”
Section: Discussionmentioning
confidence: 64%
“…Only acute tiapride treatment leads to a significant reduction of dopamine and DOPAC, while HVA remained unchanged. Satoh et al [25] also found a slight reduction of dopamine in the striatum upon giving a single acute dose of tiapride (100 mg/kg, i. p.) to Wistar rats aged 42±63 days. On the other hand, DOPAC and HVA were increased 2 hours, but not 3 days, after the acute dose of tiapride.…”
Section: Discussionmentioning
confidence: 91%
“…In contrast to the findings for haloperidol (Ziemann et al, 1997), tiapride did not significantly alter baseline CE. The differential effects may be due to dosage or divergent pharmacological profiles of these DA-antagonists (Kohler et al, 1984; Satoh et al, 1987). Other studies found enhanced CE after motor training alone (Abbruzzese et al, 1996; Muellbacher et al, 2001; Koeneke et al, 2006; Cirillo et al, 2010, 2011).…”
Section: Discussionmentioning
confidence: 99%